SCHEMBL25754475

SCHEMBL25754475

CC#CC(=O)COCC(N)COCCN1CCCCC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.36
KDM4E B2RXH2 2/20 0.36
MAPT P10636 3/20 0.34
THRB P10828 3/20 0.34
HRH3 Q9Y5N1 2/20 0.34
LMNA P02545 2/20 0.34
TSHR P16473 1/20 0.34
KMT2A Q03164 5/20 0.34
MEN1 O00255 1/20 0.34
GAA P10253 1/20 0.34
TP53 P04637 1/20 0.34
HTT P42858 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.33
GFER P55789 1/20 0.33
CYP1A2 P05177 1/20 0.33
CHRM2 P08172 1/20 0.33
CHRM4 P08173 1/20 0.33
CHRM5 P08912 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25754467 0.85 ABCB1 (0.36) ALDH1A1MAPTKMT2AMEN1CYP2D6
SCHEMBL25754477 0.85 ABCB1 (0.34) ALDH1A1MAPTTHRBLMNATSHR
SCHEMBL25754461 0.80 ALDH1A1 (0.36) ALDH1A1KDM4EMAPTTHRBHRH3
SCHEMBL25754605 0.79 HRH3 (0.43) ALDH1A1KDM4EHRH3KMT2AMEN1
SCHEMBL25754612 0.79 HRH3 (0.43) ALDH1A1KDM4EHRH3KMT2AMEN1
SCHEMBL25754469 0.78 ABCB1 (0.35) ALDH1A1MAPTTHRBHRH3LMNA
SCHEMBL25754425 0.77 PSMB1 (0.33) ALDH1A1KDM4EMAPTHRH3LMNA
SCHEMBL25754431 0.77 MAPT (0.34) KDM4EMAPTHRH3LMNAHTT
SCHEMBL25754521 0.76 KMT2A (0.32) ALDH1A1KDM4EHRH3LMNAKMT2A
SCHEMBL25754411 0.75 HRH3 (0.33) ALDH1A1KDM4EMAPTHRH3LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230210999-A1 TARGETED PROTEASE DEGRADATION (TED) PLATFORM EUBULUS BIOTHERAPEUTICS (HONG KONG) LIMITED (HK) 2023-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230210999-A1 TARGETED PROTEASE DEGRADATION (TED) PLATFORM UCHL3, UBE2L3, ADAM33 ALDH1A1 2539/4885KDM4E 2658/4885MAPT 1198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.